Anonymous
Guest
Anonymous
Guest
British phrasing. You at corporate in London?
Not like we have facilities in Hull, York, and Birmingham as well.....
British phrasing. You at corporate in London?
Not like we have facilities in Hull, York, and Birmingham as well.....
Well? For all of you in the know, what are you hearing?
QUOTE=Anonymous;5258539]I think you are off a month on the Stryker thing. I believe it was late May when they were looking. I could be wrong.
If Sanofi had waited another 6 mo. then I think Buhon is a stronger candidate. As of now, he has 6 more months on his S&N contract.
If Styker were to make an offer (and I don't think they will), the outgoing CEO is usually asked to stay until the deal closes... So, if Olivier Buhon wants to be the new CEO of the largest French Pharma company, he should NOT make a deal with Stryker that will tie him up for the next 10-12 months... or better yet, QUIT NOW.
It won't matter though. Remember what those Englishmen said? "Meet the new boss... Same as the old boss......... DON'T GET FOOLED, AGAIN"
Medical device maker Smith & Nephew CEO: Big not always beautiful
http://www.reuters.com/article/2015/01/13/smithandnephew-strategy-idUSL1N0US03220150113
Silence once again.......time to wait another year for buyout rumors to start again
Such a massive payout to reaped by executive management at the estimated +13£ per share buyout price, be assured S&N brass desires a Stryker buyout.
Might this message simply be an attempt to chat the stock down a bit before the imminent purchase? The order coming from our new masters in Kalamazoo?
If that's the case, is it too much to ask for some leadership and vision from this group of bumbling idiots. Focus on the emerging markets and acauiring the distributorships in other countries just aint cutting it here.